Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-16

Clinical Trial Update: Safety and Efficacy of ZP-Glucagon to Injectable Glucagon for Hypoglycemia [Phase 1]

View source ↗

Summary

Phase 1 trial update reports safety and efficacy data for ZP-Glucagon as an injectable glucagon for treating hypoglycemia, evaluated against standard injectable…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Injectable Glucagon (glucagon)
  • ZP-Glucagon (glucagon)

Snippet

Sponsor: Zosano Pharma Corporation | Conditions: Hypoglycemia | Phase 1 | Status: COMPLETED